Trial record 1 of 1 for:
NCT05496595
DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05496595 |
Recruitment Status :
Terminated
(Review of Data, and our other compound is a better option)
First Posted : August 11, 2022
Last Update Posted : March 6, 2024
|
Sponsor:
DynamiCure Biotechnology
Information provided by (Responsible Party):
DynamiCure Biotechnology
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | February 5, 2024 |
Actual Study Completion Date : | February 5, 2024 |